首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   357篇
  国内免费   3篇
  完全免费   26篇
  神经病学   386篇
  2019年   8篇
  2018年   12篇
  2017年   25篇
  2016年   14篇
  2015年   12篇
  2014年   22篇
  2013年   29篇
  2012年   20篇
  2011年   31篇
  2010年   25篇
  2009年   38篇
  2008年   27篇
  2007年   24篇
  2006年   13篇
  2005年   8篇
  2004年   9篇
  2003年   15篇
  2002年   19篇
  2001年   8篇
  1999年   5篇
  1998年   3篇
  1997年   4篇
  1996年   2篇
  1995年   2篇
  1994年   1篇
  1993年   2篇
  1991年   2篇
  1989年   2篇
  1984年   1篇
  1983年   1篇
  1982年   2篇
排序方式: 共有386条查询结果,搜索用时 31 毫秒
1.
OBJECTIVE: The purpose of this study was to examine whether there is a bidirectional relationship between, on one hand, anxiety and depression and, on the other hand, insomnia over the course of a year. METHODS: A randomly selected sample of 3000 participants from the general population filled out a baseline survey (N=1812) and a 1-year follow-up survey (N=1498) on anxiety, depression, and insomnia. RESULTS: On cross-sectional analyses, bivariate correlations showed that anxiety, depression, and insomnia were significantly intercorrelated (varphi=.31-.54). On prospective analyses, logistic regression analyses demonstrated that anxiety at baseline [odds ratio (OR)=4.27 (8% of variance)] and depression at baseline [OR=2.28 (2% of variance)] were related to new cases of insomnia on follow-up. Furthermore, insomnia at baseline was related to new episodes of high anxiety and high depression on follow-up [OR=2.30 (2% of variance) and OR=3.51 (4% of variance), respectively]. CONCLUSION: Evidence suggests that there is a bidirectional relationship between, on one hand, anxiety and depression and, on the other hand, insomnia. This suggests that anxiety, depression, and insomnia are intertwined over time, implying implications for theoretical conceptualizations and interventions.  相似文献
2.
认知行为治疗对失眠症患者的治疗作用   总被引:4,自引:0,他引:4  
目的 探讨认知行为治疗(CBT)对长期服用苯二氮卓艹类药物(BZD)的失眠症患者其睡眠质量、心理健康状况及BZD使用的改善作用,以提高对失眠症的疗效.方法 选择服用BZD治疗3个月以上的失眠症患者64例,随机分为单纯药物治疗组及药物治疗联合认知行为治疗组(联合治疗组),药物组BZD逐步减量,联合治疗组在BZD逐步减量的同时给予CBT治疗,共治疗6~8周.治疗前后采用症状自评量表(SCL-90)、自我和谐量表(SCCS)评价患者心理健康水平,匹兹堡睡眠质量指数(PSQI)评定临床疗效,并比较两组BZD的使用情况.结果 治疗结束后,比较药物治疗组、联合治疗组SCL-90总分[分别为(173.2 ± 41.3)和(147.6±23.6),t=5.696,P<0.01]、抑郁[分别为(2.3±0.6)和(1.9±0.4),t=3.799,P<0.01]、焦虑[分别为(2.2±0.7)和(1.7±0.3),t=4.792,P<0.01]等因子分及SCCS总分[分别为(96.8±11.5)和(87.8±9.3),t=5.067,P<0.01]、不和谐度因子分[分别为(48.7±8.1)和(40.7±6.9),t=4.508,P<0.01],联合治疗组评分显著低于药物治疗组;PSQI睡眠质量[分别为(14.4±2.9)和(9.0±1.8),t=6.902,P<0.01]、催眠药物[分别为(1.9±0.9)和(1.3±0.6),t=6.759,P<0.01]、日间功能等因子分[分别为(2.6±0.6)和(1.8±0.9),t=3.645,P<0.01],联合治疗组得分显著低于药物治疗组.联合治疗组临床显效率为55.2%,优于药物治疗组的17.8%,差异有统计学意义(χ2=18.57,P<0.01);联合治疗组BZD减药量明显大于药物组,差异有统计学意义(χ2=16.32,P<0.01).结论 CBT可提高失眠症患者的心理健康水平,改善患者的睡眠质量和情绪症状,并可帮助患者减少BZD药物的用量,降低药物依赖的发生.  相似文献
3.
失眠症患者心理社会因素分析   总被引:3,自引:0,他引:3  
目的:探讨失眠症患者的应付方式,心理健康状况和社会支持状况.方法:采用应付方式问卷(CSQ)、症状自评量表(SCL-90)和社会支持量表(SSS)对失眠症患者和正常对照者各88例进行测评.结果:失眠症组自责、幻想和退避分量表的得分显著高于对照组,求助分量表的得分显著低于对照组(P<0.01);失眠症组SCL-90总分及躯体化、抑郁、焦虑、睡眠障碍各因子分与对照组比较,有显著差异(P<0.01).失眠症组社会支持总分、客观支持和对社会支持的利用度评分显著低于正常对照组(P<0.05).失眠症组自责与躯体化症状、焦虑、抑郁等因子及总分呈显著正相关,而求助与焦虑、抑郁、偏执和总分呈显著负相关(P<0.05).结论:失眠症患者多采用不成熟的应付方式,且有较多的心身症状,应付方式和身心健康有相关性.失眠症患者缺乏社会支持.  相似文献
4.
家族性致死性失眠症临床及相关特征(附1例报道)   总被引:3,自引:0,他引:3  
目的研究1例家族性致死性失眠症(Familial Fatal Insomnia,FFI)的临床及相关特征。方法分析家族性致死性失眠症患者的临床特征、动态脑电图正电子发射计算机断层扫描及基因测序等相关检查结果。结果朊蛋白基因分析基因D178N突变,并与129Met等位基因连锁;动态脑电图检查未见睡梭波出现,慢波睡眠明显减少;正电子发射计算机断层扫描显示丘脑代谢明显降低。结论家族性致死性失眠症具有特征性的临床、基因学、动态脑电图及正电子发射计算机断层扫描影像学改变。  相似文献
5.
OBJECTIVE: This study examined the relationship of psychological and health-related quality of life variables to insomnia in a population-based sample. METHODS: Data were derived from a longitudinal epidemiological study assessing the natural history of insomnia. The present results are based on the first of four postal evaluations conducted over a 2-year period. Participants (n=953) completed questionnaires assessing sleep, psychological and personality variables, and health-related factors. Participants were categorized into three sleep status subgroups using an algorithm based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision and International Classification of Diseases, 10th Edition diagnostic criteria for insomnia: (1) insomnia syndrome (n=147), (2) insomnia symptoms (n=308), and (3) good sleepers (n=493). RESULTS: Compared to individuals with insomnia symptoms and good sleepers, individuals with insomnia syndrome presented lower quality of life and higher scores on measures of depression, anxiety, neuroticism, extraversion, arousal predisposition, stress perception, and emotion-oriented coping. The same pattern was observed for individuals with insomnia symptoms in comparison with good sleepers. An ordinal logistic regression analysis showed that the presence of a past episode of insomnia, higher depressive symptoms, and lower scores on the 12-item Short Form Health Survey vitality and role physical subscales were the most useful variables to predict subgroups membership. CONCLUSION: The findings indicate that insomnia is associated with increased psychological symptomatology and perceived stress, higher predisposition to arousal, and more impairment of health quality. Longitudinal follow-ups are now being conducted to assess the relative contribution of those variables in the development and natural course of insomnia.  相似文献
6.
The effects of lamotrigine on sleep in patients with epilepsy   总被引:1,自引:1,他引:6  
Foldvary N  Perry M  Lee J  Dinner D  Morris HH 《Epilepsia》2001,42(12):1569-1573
PURPOSE: The older antiepileptic drugs (AEDs) have a variety of effects on sleep, including marked reduction in REM, slow-wave sleep (SWS) and sleep latency, and increased percentage of light sleep. The effects of the newer AEDs on sleep are unknown. Our purpose was to study the effect of lamotrigine (LTG) on sleep. METHODS: Ten adults with focal epilepsy, in whom the decision was made to add LTG to either phenytoin (PHT) or carbamazepine (CBZ) for control of seizures, were the subjects of this study. Patients underwent pre- and posttreatment polysomnography (PSG) and completed sleep questionnaires. Polygraphic variables and Epworth Sleepiness Scale (ESS) scores, a subjective measure of sleep propensity, were compared by using the Wilcoxon sign rank test. RESULTS: Seven patients were taking CBZ, and three were treated with PHT. All subjects were titrated to an LTG dose of 400 mg/day. Treatment with LTG produced a significant decrease in SWS and an increase in stage 2 sleep percentage. No significant difference in ESS or any of the other polygraphic variables was observed. However, LTG treatment was associated with a reduction in arousals and stage shifts and an increase in REM periods. No subjects reported insomnia with treatment. CONCLUSIONS: LTG appears to be less disruptive to sleep than some of the older AEDs.  相似文献
7.
Pediatric Sleep-Wake Disorders   总被引:1,自引:0,他引:1  
8.
致死性家族性失眠症一例的临床、病理及基因特征   总被引:1,自引:1,他引:0  
目的 研究致死性家族性失眠症(fatal familial insomnia,FFI)患者的临床、病理及基因特征,并复习相关文献.方法 分析1例FFI患者的临床特点,对死亡患者进行尸检和脑组织病理检查,并对患者及其家属血标本进行朊蛋白基因(PRNP)检测.结果 该例患者的主要临床特征包括顽固性失眠、精神和夜间睡眠行为异常、行走不稳、吞咽困难、突然死亡以及阳性家族史.患者多处脑组织神经元丢失及胶质细胞增生,以丘脑为重;患者及其1名亲属PRNP检测分析显示D178N基因突变,并与129位甲硫氨酸等位基因连锁.结论 FFI患者可表现为猝死,可有突出的精神症状;无症状携带者可出现相应基因突变;提供尸检和脑组织病理资料有助于进一步认识本病.  相似文献
9.
基诺族失眠状况随访研究   总被引:1,自引:0,他引:1  
目的:调查基诺族失眠发生率及其特点。方法:采取一般健康问卷12项(GHQ-12)对基诺乡44个自然村的部分人口进行疾病筛查与入户访谈,以美国精神障碍诊断与统计手册第4版为诊断标准进行诊断,收集人口学和病史资料。结果:1984人完成调查,失眠患者318例,发生率16.03%。结论:基诺族失眠发生率较低。  相似文献
10.
抑郁障碍并存焦虑或失眠症状的药物治疗对照研究   总被引:1,自引:0,他引:1  
目的:对双相和单相抑郁障碍并存焦虑、失眠症状的患者,在应用抗抑郁药治疗的对照研究时,加用苯二氮艹卓类药物进行疗效和不良反应观察。方法:将双相和单相抑郁障碍患者各32例,再随机分为文拉法辛合并小剂量舒必利治疗组(合用组)及单用文拉法辛治疗组(对照组),治疗6周。期间对入组治疗前即有焦虑、失眠症状者加用阿普唑仑或氯硝西泮,然后分别在治疗前后用汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA),匹兹堡睡眠质量指数(PSQI),和治疗中出现的症状量表(TESS)进行疗效和不良反应评定。结果:双相和单相抑郁患者不但抑郁症状明显改善,而且均未发生明显转躁,焦虑和失眠症状也有明显改善。HAMD、HAMA和PSQI的评分均有明显降低(P〈0.001)。但治疗过程中,不论双相合用组,还是单相合用组,均在连续并用苯二氮卓艹类药物4周后,难以减少该类药物用量或停药。结论:双相和单相抑郁患者用文拉法辛并小量舒必利或者单用文拉法辛治疗时,如伴有明显焦虑、失眠,可并用苯二氮卓艹类药物以争取更好疗效。  相似文献
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号